Product Images 2% Lidocaine Hci

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 18 images provide visual information about the product associated with 2% Lidocaine Hci NDC 51662-1467 by Hf Acquisition Co Llc, Dba Healthfirst, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

51662-1465-1 SERIALIZED LABELING - 51662 1465 1 Serialized Labeling

51662-1465-1 SERIALIZED LABELING - 51662 1465 1 Serialized Labeling

This appears to be a product label or packaging information for an injection with the dosage of 200mg/20mL. It contains information about the manufacturer, distributor, and lot number.*

PRINCIPAL DISPLAY PANEL - 51662-1465-1 20 mL VIAL LABEL OPT 1 - 51662 1465 1 Vial Label Opt 1

PRINCIPAL DISPLAY PANEL - 51662-1465-1  20 mL VIAL LABEL OPT 1 - 51662 1465 1 Vial Label Opt 1

This document is a label or package insert for a product called NDC 0409-4276-16, which is a 20mL solution of Lidocaine Hydrochloride for infiltration and nerve block. The solution contains lidocaine hydrochloride, sodium chloride, and methylparaben as preservative. It is sterile, non-pyrogenic, and has a pH of 6.5. The product is not intended for oral or caudal use, and the usual dosage should be determined according to appropriate medical guidelines. The manufacturer is Hospira, Inc. located in Lake Forest, IL, USA.*

PRINCIPAL DISPLAY PANEL - 51662-1465-1 20 mL VIAL LABEL OPT 2 - 51662 1465 1 Vial Label Opt 2

PRINCIPAL DISPLAY PANEL - 51662-1465-1  20 mL VIAL LABEL OPT 2 - 51662 1465 1 Vial Label Opt 2

PRINCIPAL DISPLAY PANEL - 51662-1465-1 20 mL VIAL LABEL OPT 3 - 51662 1465 1 Vial Label Opt 3

PRINCIPAL DISPLAY PANEL - 51662-1465-1  20 mL VIAL LABEL OPT 3 - 51662 1465 1 Vial Label Opt 3

This is a description for a medication called Lidocaine HCI Injection, USP. It has a concentration of 200 mg/20 mL (10 mg/mL) and is used for infiltration and nerve block. The medication may contain HCl and/or NaOH for pH adjustment and has a pH of 6.5 (5.0 to 7). It is sterile, nonpyrogenic, and has a usual dosage that can be found in the insert. It is stored at 20-25°C (68-77°F) and is distributed by Hospia Inc, located in Lake Forest, IL.*

PRINCIPAL DISPLAY PANEL - 51662-1465-1 20 mL VIAL LABEL OPT 4 - 51662 1465 1 Vial Label Opt 4

PRINCIPAL DISPLAY PANEL - 51662-1465-1  20 mL VIAL LABEL OPT 4 - 51662 1465 1 Vial Label Opt 4

This appears to be a description of a medication that is a Lidocaine injection used for infiltration and nerve block. The medication is supplied in a 20 mL vial and each mL contains 7 mg of Lidocaine hydrochloride. The medication may be mixed with HC and/or NaOH for administration. The vial should be stored at room temperature.*

PRINCIPAL DISPLAY PANEL - SERIALIZED LABELING 51662-1467-1 20 mL VIAL - 51662 1467 1 Serialized Labeling

PRINCIPAL DISPLAY PANEL - SERIALIZED LABELING 51662-1467-1  20 mL VIAL - 51662 1467 1 Serialized Labeling

This is a pharmaceutical product packaged in a 20 ml bottle with the code "03543DK". There are several identification numbers associated with the product, including a UPC code, a date of production, and a unique identification number. The label includes the standard "RX only" warning, indicating that the product is available only with a prescription. The manufacturer is a company named HF Acquisition Co., LLC and the product insert should be consulted for additional information.*

PRINCIPAL DISPLAY PANEL - 51662-1467-1 20 mL VIAL LABEL OPT 1 - 51662 1467 1 Vial LAbel Opt 1

PRINCIPAL DISPLAY PANEL - 51662-1467-1  20 mL VIAL LABEL OPT 1 - 51662 1467 1 Vial LAbel Opt 1

This is a description of Lidocaine HCI Injection, which contains Lidocaine with certain additives and comes in a 20ml vial. It is suggested for use as an anesthetic. The injection is nonpyrogenic, and may contain ingredients to adjust the pH. It has a recommended dosage of 400mg/20ml and should be stored at controlled room temperature. The manufacturer is Hospira, Inc.*

PRINCIPAL DISPLAY PANEL - 51662-1467-1 20 mL VIAL LABEL OPT 2 - 51662 1467 1 Vial Label Opt 2

PRINCIPAL DISPLAY PANEL - 51662-1467-1  20 mL VIAL LABEL OPT 2 - 51662 1467 1 Vial Label Opt 2

This is a description of a Lidocaine HCI (injection, USP) medication with a strength of 400 mg/20 mL (20 mg/mL). It is intended for infiltration and nerve block, and its usual dosage can be found in the insert. The medication is sterile and non-pyrogenic, and may contain sodium chloride for pH adjustment. It is recommended to store the medication between 20 to 25°C (68 to 77°F). The medication is distributed by Hospira, Inc, located in Lake Forest, IL 60045 USA.*

PRINCIPAL DISPLAY PANEL - 51662-1467-1 20 mL VIAL LABEL OPT 3 - 51662 1467 1 Vial Label Opt 3

PRINCIPAL DISPLAY PANEL - 51662-1467-1  20 mL VIAL LABEL OPT 3 - 51662 1467 1 Vial Label Opt 3

This is a medical solution called 20mL T2% Injection, which is administered through infiltration and nerve block. It cannot be used for epidural and caudal purposes. It contains lidocaine hydrochloride, sodium chloride, and methylparaben. Adjusted to pH 6.5, it is sterile and non-pyrogenic. The usual dosage information is available in the insert. The solution comes with a preservative and should be stored at a temperature between 20°C to 25°C.*

PRINCIPAL DISPLAY PANEL - 51662-1467-1 20 mL VIAL LABEL OPT 4 - 51662 1467 1 Vial Label Opt 4

PRINCIPAL DISPLAY PANEL - 51662-1467-1  20 mL VIAL LABEL OPT 4 - 51662 1467 1 Vial Label Opt 4

DESCRIPTION - Description

DESCRIPTION - Description

This appears to be the concentration of lidocaine HC and sodium chloride in different milligrams per milliliter (mg/mL) measurements. Lidocaine HC (anhyd.) is available in concentrations of 5, 10, 15 and 20 mg/mL, while sodium chloride solutions range from 6 to 8 mg/mL.*

D & A 1 - Dosage and Administration 1

D & A 1 - Dosage and Administration 1

D a A 2 - Dosage and Administration 2

D a A 2 - Dosage and Administration 2

This is a table outlining recommended concentrations, volumes, and total doses of Lidocaine Hydrochloride Injection, USP for various medical procedures such as infiltration, peripheral nerve blocks, and central neural blocks. The table also specifies the recommended concentration and volume for dental procedures, and obstetrical analgesia. The text does not provide any further information regarding the product or the procedures.*

HOW SUPPLIED 1 - How Supplied 1

HOW SUPPLIED 1 - How Supplied 1

Unit of Sale Concentration: This appears to be a list of pharmaceutical products with their respective concentrations, packaging details, and National Drug Code (NDC) numbers. The products are available as vials or ampuls, with concentrations ranging from 0.5% to 2%, and quantities varying from trays of 25 to cases of 800. The listed concentration for each product represents the amount of active ingredient per milliliter of solution.*

HOW SUPPLIED 2 - How Supplied 2

HOW SUPPLIED 2 - How Supplied 2

This text provides information on different bundles and trays containing specific concentrations of medication. The bundles and trays each have unique National Drug Codes (NDC) assigned by the FDA, and each contains a specified number of clamcells, ampuls, or plastic fliptop vials. The concentrations of medication per unit range from 5 mg/mL to 20 mg/mL.*

LOGO - Logo

LOGO - Logo

PRECAUTIONS - Precautions

PRECAUTIONS - Precautions

This is a list of various classes of drugs with specific examples under them. It includes nitrates/nitrites, local anesthetics, antineoplastic, antibiotics, antimalarials, anticonvulsants, and other drugs such as acetaminophen, metoclopramide, quinine, and sulfasalazine.*

STRUCTURE - Structure

STRUCTURE - Structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.